{"description":"At each visit the investigator had to document any occurrence of adverse events and abnormal laboratory findings. Any event spontaneously reported by the participant or observed by the investigator was recorded, irrespective of the relation to study treatment.","eventGroups":[{"description":"Ixazomib citrate, 0.24 to 3.95 mg/m\\^2, capsules, orally, once weekly on Days 1, 8, and 15 of a 28-day cycle in the Dose Escalation period. All dose amounts are expressed as the dose of ixazomib, the biologically active moiety of ixazomib citrate.","id":"EG000","otherNumAffected":30,"otherNumAtRisk":32,"seriousNumAffected":7,"seriousNumAtRisk":32,"title":"Dose Escalation Cohorts"},{"description":"Ixazomib citrate, 2.97 mg/m\\^2 established MTD, capsules, orally, once weekly on Days 1, 8, and 15 of a 28-day cycle in the Expansion Period. All dose amounts are expressed as the dose of ixazomib, the biologically active moiety of ixazomib citrate.","id":"EG001","otherNumAffected":31,"otherNumAtRisk":31,"seriousNumAffected":15,"seriousNumAtRisk":31,"title":"Expansion Cohorts"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":32},{"groupId":"EG001","numAffected":10,"numAtRisk":31}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":32},{"groupId":"EG001","numAffected":7,"numAtRisk":31}],"term":"Leukopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":32},{"groupId":"EG001","numAffected":10,"numAtRisk":31}],"term":"Lymphopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":32},{"groupId":"EG001","numAffected":11,"numAtRisk":31}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":32},{"groupId":"EG001","numAffected":17,"numAtRisk":31}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":31}],"term":"Lacrimation increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":4,"numAtRisk":31}],"term":"Abdominal discomfort"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":31}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":32},{"groupId":"EG001","numAffected":6,"numAtRisk":31}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":31}],"term":"Flatulence"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Asthenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":32},{"groupId":"EG001","numAffected":4,"numAtRisk":31}],"term":"Chills"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":32},{"groupId":"EG001","numAffected":17,"numAtRisk":31}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":31}],"term":"Influenza like illness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":6,"numAtRisk":31}],"term":"Oedema peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":31}],"term":"Cellulitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":32},{"groupId":"EG001","numAffected":4,"numAtRisk":31}],"term":"Upper respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Contusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Blood bicarbonate decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":32},{"groupId":"EG001","numAffected":7,"numAtRisk":31}],"term":"Weight decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":32},{"groupId":"EG001","numAffected":14,"numAtRisk":31}],"term":"Decreased appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Hyperglycaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Hyperuricaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Hypoalbuminaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":31}],"term":"Hypocalcaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":32},{"groupId":"EG001","numAffected":4,"numAtRisk":31}],"term":"Hyponatraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":32},{"groupId":"EG001","numAffected":4,"numAtRisk":31}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Muscle spasms"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":31}],"term":"Muscular weakness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":31}],"term":"Musculoskeletal chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":31}],"term":"Musculoskeletal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Myalgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":5,"numAtRisk":31}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":32},{"groupId":"EG001","numAffected":4,"numAtRisk":31}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":32},{"groupId":"EG001","numAffected":5,"numAtRisk":31}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":32},{"groupId":"EG001","numAffected":7,"numAtRisk":31}],"term":"Neuropathy peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":31}],"term":"Paraesthesia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Peripheral motor neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":31}],"term":"Peripheral sensory neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":31}],"term":"Anxiety"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Renal failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":31}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":32},{"groupId":"EG001","numAffected":5,"numAtRisk":31}],"term":"Epistaxis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":31}],"term":"Nasal congestion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Oropharyngeal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":31}],"term":"Productive cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Rhinorrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Hyperhidrosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":5,"numAtRisk":31}],"term":"Rash macular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Rash papular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":31}],"term":"Hypertension"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":32},{"groupId":"EG001","numAffected":4,"numAtRisk":31}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":31}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Stenosis or Obstruction of Ileus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":4,"numAtRisk":31}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Hepatitis B"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":31}],"term":"Abscess Neck"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Parainfluenzae virus infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Pneumonia respiratory syncytial viral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Bacteraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Hypercalcaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Dehydration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":31}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Blood creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Urinary retention"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Renal Failure Acute"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":31}],"term":"Hyperviscosity syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Cardiac failure congestive"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":31}],"term":"Multiple myeloma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":31}],"term":"Syncope"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Stevens-Johnson syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (15)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":31}],"term":"Orthostatic hypotension"}],"timeFrame":"From the first dose through 30 days after last dose of ixazomib citrate or until the start of subsequent antineoplastic therapy (Up to 354 days)"}